Literature DB >> 29383665

Cellular Uptake and Mode-of-Action of Clostridium difficile Toxins.

Panagiotis Papatheodorou1,2,3, Holger Barth4, Nigel Minton5, Klaus Aktories6.   

Abstract

Research on the human gut pathogen Clostridium difficile and its toxins has gained much attention, particularly as a consequence of the increasing threat to human health presented by emerging hypervirulent strains. Toxin A (TcdA) and B (TcdB) are the two major virulence determinants of C. difficile. Both are single-chain proteins with a similar multidomain architecture. Certain hypervirulent C. difficile strains also produce a third toxin, namely binary toxin CDT (Clostridium difficile transferase). As C. difficile toxins are the causative agents of C. difficile-associated diseases (CDAD), such as antibiotics-associated diarrhea and pseudomembranous colitis, considerable efforts have been expended to unravel their molecular mode-of-action and the cellular mechanisms responsible for their uptake. Notably, a high proportion of studies on C. difficile toxins were performed in European laboratories. In this chapter we will highlight important recent advances in C. difficile toxins research.

Entities:  

Keywords:  Bacterial disease; Bacterial toxins; Clostridium difficile; Toxin receptor; Toxin uptake

Mesh:

Substances:

Year:  2018        PMID: 29383665     DOI: 10.1007/978-3-319-72799-8_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  19 in total

1.  C910 chemical compound inhibits the traffiking of several bacterial AB toxins with cross-protection against influenza virus.

Authors:  Yu Wu; Nassim Mahtal; Eléa Paillares; Léa Swistak; Sara Sagadiev; Mridu Acharya; Caroline Demeret; Sylvie Van Der Werf; Florence Guivel-Benhassine; Olivier Schwartz; Serena Petracchini; Amel Mettouchi; Lucie Caramelle; Pierre Couvineau; Robert Thai; Peggy Barbe; Mathilde Keck; Priscille Brodin; Arnaud Machelart; Valentin Sencio; François Trottein; Martin Sachse; Gaëtan Chicanne; Bernard Payrastre; Florian Ville; Victor Kreis; Michel-Robert Popoff; Ludger Johannes; Jean-Christophe Cintrat; Julien Barbier; Daniel Gillet; Emmanuel Lemichez
Journal:  iScience       Date:  2022-06-06

Review 2.  Capturing the environment of the Clostridioides difficile infection cycle.

Authors:  Matthew K Schnizlein; Vincent B Young
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-04-25       Impact factor: 73.082

Review 3.  Use of Short-Chain Fatty Acids for the Recovery of the Intestinal Epithelial Barrier Affected by Bacterial Toxins.

Authors:  Diliana Pérez-Reytor; Carlos Puebla; Eduardo Karahanian; Katherine García
Journal:  Front Physiol       Date:  2021-05-24       Impact factor: 4.566

4.  Intoxication of mammalian cells with binary clostridial enterotoxins is inhibited by the combination of pharmacological chaperone inhibitors.

Authors:  Katharina Ernst; Judith Sailer; Maria Braune; Holger Barth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-12-07       Impact factor: 3.000

5.  Novel Chimeric Protein Vaccines Against Clostridium difficile Infection.

Authors:  Shaohui Wang; Yuanguo Wang; Ying Cai; Ciaran P Kelly; Xingmin Sun
Journal:  Front Immunol       Date:  2018-10-22       Impact factor: 7.561

6.  A Drosophila Model for Clostridium difficile Toxin CDT Reveals Interactions with Multiple Effector Pathways.

Authors:  Ruth Schwartz; Annabel Guichard; Nathalie C Franc; Sitara Roy; Ethan Bier
Journal:  iScience       Date:  2020-01-25

7.  Characterization and Pharmacological Inhibition of the Pore-Forming Clostridioides difficile CDTb Toxin.

Authors:  Katharina Ernst; Marc Landenberger; Julian Nieland; Katharina Nørgaard; Manfred Frick; Giorgio Fois; Roland Benz; Holger Barth
Journal:  Toxins (Basel)       Date:  2021-05-28       Impact factor: 4.546

8.  Combined Pharmacological Inhibition of Cyclophilins, FK506-Binding Proteins, Hsp90, and Hsp70 Protects Cells From Clostridium botulinum C2 Toxin.

Authors:  Katharina Ernst; Carolin Kling; Marc Landenberger; Holger Barth
Journal:  Front Pharmacol       Date:  2018-11-13       Impact factor: 5.810

9.  Low Density Lipoprotein Receptor-Related Protein-1 (LRP1) Is Involved in the Uptake of Clostridioides difficile Toxin A and Serves as an Internalizing Receptor.

Authors:  Dennis Schöttelndreier; Anna Langejürgen; Robert Lindner; Harald Genth
Journal:  Front Cell Infect Microbiol       Date:  2020-10-19       Impact factor: 5.293

10.  The cytotoxic synergy between Clostridioides difficile toxin B and proinflammatory cytokines: an unholy alliance favoring the onset of Clostridioides difficile infection and relapses.

Authors:  Gabrio Bassotti; Andrea Marchegiani; Pierfrancesco Marconi; Katia Fettucciari
Journal:  Microbiologyopen       Date:  2020-07-12       Impact factor: 3.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.